Literature DB >> 23044562

Immunohistochemical profile of HIF-1α, VEGF-A, VEGFR2 and MMP9 proteins in tegumentary leishmaniasis.

Carlos Alberto de Carvalho Fraga1, Marcos Vinicius Macedo de Oliveira, Lucas Rodrigues Alves, Agostinho Gonçalves Viana, Adriana Alkmin de Sousa, Sílvio Fernando Guimarães Carvalho, Alfredo Maurício Batista De Paula, Ana Cristina de Carvalho Botelho, André Luiz Sena Guimarães.   

Abstract

BACKGROUND: Leishmaniasis is one of the most important infectious diseases worldwide. Our study can provide more knowledge about angiogenic and hypoxic events in leishmaniasis. We attempted to verify whether the HIF-1 α protein expression may be associated to VEGF-A, VEGFR2 and MMP9 in leishmanial lesions.
OBJECTIVES: Besides understanding the pathway, we performed the correlation of VEGF-A, VEGFR2 and MMP9 proteins.
METHODS: In this study, we gathered 54 paraffin blocks taken from skin lesions in patients from northern Minas Gerais, Brazil, with confirmed diagnosis of tegumentary leishmaniasis. Immunohistochemistry was used to evaluate the expression of the proteins. The expression of HIF-1α was categorized into two groups according to the median: HIF-1 α lower and HIF-1 α higher.
RESULTS: We observed increase of VEGFR2 and MMP9 protein expressions in HIF-1 α higher group of epithelial cells. Spearman analyses in epithelial cells showed correlation between VEGF-A and MMP9, VEGFR2 and MMP9 protein expression.
CONCLUSIONS: HIF-1 α higher group showed increase of VEGFR2 and MMP9 proteins. In epithelial cells, VEGF-A was correlated to MMP9 protein. Furthermore, considering leukocyte cells, VEGFR2 was negatively correlated to MMP9 protein levels. This pathway possibly prepares the cells for a higher activity in a hypoxic or an angiogenic microenvironment. Other in vitro and in vivo studies may clarify the activation mechanism and the response from the proteins HIF-1 α, VEGFR2 and MMP-9 in tegumentary leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23044562     DOI: 10.1590/s0365-05962012000500006

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  6 in total

1.  Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease.

Authors:  Tiffany Weinkopff; Christoph Konradt; David A Christian; Dennis E Discher; Christopher A Hunter; Phillip Scott
Journal:  J Immunol       Date:  2016-07-29       Impact factor: 5.422

2.  Leishmania Infection Induces Macrophage Vascular Endothelial Growth Factor A Production in an ARNT/HIF-Dependent Manner.

Authors:  Tiffany Weinkopff; Hayden Roys; Anne Bowlin; Phillip Scott
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

3.  Hypoxia-Inducible Factor Signaling in Macrophages Promotes Lymphangiogenesis in Leishmania major Infection.

Authors:  Anne Bowlin; Hayden Roys; Humphrey Wanjala; Manjunath Bettadapura; Gopinath Venugopal; Jessica Surma; M Celeste Simon; Tiffany Weinkopff
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

4.  Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis.

Authors:  Maíra G Saldanha; Adriano Queiroz; Paulo Roberto L Machado; Lucas P de Carvalho; Phillip Scott; Edgar M de Carvalho Filho; Sérgio Arruda
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

5.  HIF-α Activation Impacts Macrophage Function during Murine Leishmania major Infection.

Authors:  Manjunath Bettadapura; Hayden Roys; Anne Bowlin; Gopinath Venugopal; Charity L Washam; Lucy Fry; Steven Murdock; Humphrey Wanjala; Stephanie D Byrum; Tiffany Weinkopff
Journal:  Pathogens       Date:  2021-12-06

6.  miR-548d-3p Alters Parasite Growth and Inflammation in Leishmania (Viannia) braziliensis Infection.

Authors:  Marina de Assis Souza; Eduardo Milton Ramos-Sanchez; Sandra Márcia Muxel; Dimitris Lagos; Luiza Campos Reis; Valéria Rêgo Alves Pereira; Maria Edileuza Felinto Brito; Ricardo Andrade Zampieri; Paul Martin Kaye; Lucile Maria Floeter-Winter; Hiro Goto
Journal:  Front Cell Infect Microbiol       Date:  2021-06-10       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.